Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Paul Chubb

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
The Clinical Biochemist. Reviews|February 19, 2009
Hyponatremia treatment guidelines 2007: expert panel recommendationsS A Paul Chubb
Clinical Biochemistry|April 17, 2012
Measurement of C-terminal telopeptide of type I collagen (CTX) in serumS A Paul Chubb
BMJ (Clinical Research Ed.)|February 18, 2010
Vitamin D deficiency. What should we be doing?S A Paul Chubb, Zahra Khatami
Endocrine|February 25, 2016
The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosisSamuel D Vasikaran, S A Paul Chubb
Pathology|January 21, 2026
Proposed common reference intervals for reference bone turnover markers in osteoporosisS A Paul Chubb, Samuel D Vasikaran
Clinical Biochemistry|December 19, 2015
Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosisS A Paul Chubb, Christine Mandelt, Samuel Vasikaran
The Clinical Biochemist. Reviews|October 21, 2009
Reporting of quantitative protein electrophoresis in Australia and New Zealand: a call for standardisationZoe Inman, Helen Martin, S A Paul Chubb
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2018
Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adultsPaul Glendenning, S A Paul Chubb, Samuel Vasikaran
Pathology|May 7, 2014
Towards optimising the provision of laboratory services for bone turnover markersSamuel D Vasikaran, S A Paul Chubb, Hans-Gerhard Schneider
Clinical Biochemistry|March 17, 2015
Comparison of results from commercial assays for plasma CTX: The need for harmonizationS A Paul Chubb, Christine D Mandelt, Samuel D Vasikaran
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
The Clinical Biochemist. Reviews|February 19, 2009
Hyponatremia treatment guidelines 2007: expert panel recommendationsS A Paul Chubb
Clinical Biochemistry|April 17, 2012
Measurement of C-terminal telopeptide of type I collagen (CTX) in serumS A Paul Chubb
BMJ (Clinical Research Ed.)|February 18, 2010
Vitamin D deficiency. What should we be doing?S A Paul Chubb, Zahra Khatami
Endocrine|February 25, 2016
The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosisSamuel D Vasikaran, S A Paul Chubb
Pathology|January 21, 2026
Proposed common reference intervals for reference bone turnover markers in osteoporosisS A Paul Chubb, Samuel D Vasikaran
Clinical Biochemistry|December 19, 2015
Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosisS A Paul Chubb, Christine Mandelt, Samuel Vasikaran
The Clinical Biochemist. Reviews|October 21, 2009
Reporting of quantitative protein electrophoresis in Australia and New Zealand: a call for standardisationZoe Inman, Helen Martin, S A Paul Chubb
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2018
Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adultsPaul Glendenning, S A Paul Chubb, Samuel Vasikaran
Pathology|May 7, 2014
Towards optimising the provision of laboratory services for bone turnover markersSamuel D Vasikaran, S A Paul Chubb, Hans-Gerhard Schneider
Clinical Biochemistry|March 17, 2015
Comparison of results from commercial assays for plasma CTX: The need for harmonizationS A Paul Chubb, Christine D Mandelt, Samuel D Vasikaran
Pageof 8